Introduction: Hospital at home (HAH) is a service that provides home-based nursing and rehabilitation services whose aim is to prevent admission or to facilitate early discharge from care in an acute hospital.
Methods: We evaluated the effectiveness of early discharge hospital at home (HAH) schemes for hip fracture patients over a 27-year period in a district general hospital in the United Kingdom. A long-term database for audit and research purposes is maintained for all hip fracture patients admitted to Peterborough City Hospital. The data were analysed retrospectively and patients were followed up routinely for six weeks after discharge.
Results: As many as 8876 patients were admitted with a hip fracture between 1st January 1987 and 31st December 2014, of which 5512 patients were eligible for one of the two available HAH schemes. The proportion of eligible patients discharged to the HAH schemes, and their hospital stay and readmission rates were measured; 1786 patients were discharged to a HAH scheme. The proportion of patients discharged to the scheme progressively reduced from a maximum of 94% to a minimum of 13% over the study period. The length of hospital stay until discharge to the scheme progressively increased from a mean of eight days to 18 days.
Discussion: We conclude that HAH schemes can potentially reduce the length of hospital stay of hip fracture patients but continued resources and service organisation have to be provided to match the increasing demand to prevent the service from becoming ineffective.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646172 | PMC |
| http://dx.doi.org/10.1051/sicotj/2017047 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Immunotherapeutic Potential of Mollusk Hemocyanins in Murine Model of Melanoma.
Mar Drugs
May 2024
Department of Immunology, Stefan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Acad. G. Bonchev Street, Block 26, 1113 Sofia, Bulgaria.
Unlabelled: The development of antitumor drugs and therapy requires new approaches and molecules, and products of natural origin provide intriguing alternatives for antitumor research. Gastropodan hemocyanins-multimeric copper-containing glycoproteins have been used in therapeutic vaccines and antitumor agents in many cancer models.
Materials And Methods: We established a murine model of melanoma by challenging C57BL/6 mice with a B16F10 cell line for solid tumor formation in experimental animals.
Antitumor Properties of Epitope-Specific Engineered Vaccine in Murine Model of Melanoma.
Mar Drugs
June 2022
Laboratory of Experimental Immunology, Stefan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
Finding new effective compounds of natural origin for composing anti-tumor vaccines is one of the main goals of antitumor research. Promising anti-cancer agents are the gastropodan hemocyanins-multimeric copper-containing glycoproteins used so far for therapy of different tumors. The properties of hemocyanins isolated from the marine snail (RtH) and the terrestrial snail (HaH) upon their use as carrier-proteins in conjugated vaccines, containing ganglioside mimotope GD3P4 peptide, were studied in the developed murine melanoma model.
View Article and Find Full Text PDFTreatment for multiple myeloma in hospital at home: clinical characteristics and patient care pathways.
Home Health Care Serv Q
April 2022
Cesp - Centre de Recherche En Epidémiologie Et Santé Des Populations - U1018 Inserm Ups Université Paris-Saclay, Uvsq, Hôpital Paul Brousse Villejuif Cedex Université Versailles St-Quentin, Villejuif Cedex, France.
While most patients receive anticancer injection in a conventional hospital, some are treated in hospital at home. Given the lack of data, we seek to determine the clinical characteristics and care pathways of patients benefiting from hospital at home (HAH) for anticancer injection. A longitudinal scheme was conducted about patients with multiple myeloma (MM) starting bortezomib-based regimens in HAH in 2015 with a follow-up to September 2019.
View Article and Find Full Text PDFIntegrating Home-Based Exercise Training with a Hospital at Home Service for Patients Hospitalised with Acute Exacerbations of COPD: Developing the Model Using Accelerated Experience-Based Co-Design.
Int J Chron Obstruct Pulmon Dis
July 2021
School of Health Sciences, University of East Anglia, Norwich, UK.
Background: Hospital at home (HaH) schemes allow early discharge of patients hospitalised with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Traditional outpatient pulmonary rehabilitation (PR) following an AECOPD has an established evidence-base, but there are issues with low referral, uptake and completion. One commonly cited barrier to PR post-hospitalisation relates to poor accessibility.
View Article and Find Full Text PDFBackground: The COVID-19 outbreak has posed considerable challenges to the health care system worldwide, especially for cancer treatment. We described the activity and the care organisation of the Hospitalisation At Home (HAH) structure during the pandemic for treating patients with anti-cancer injections.
Methods: We report the established organisation, the eligibility criteria, the patient characteristics, the treatment schemes and the stakeholders' role during two 5-week periods in 2020, before and during the French population's lockdown.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!